Inflammatory joint disease: The role of cytokines, cyclooxygenases and reactive oxygen species

British Journal of Biomedical Science

Volumn 53, Issue 4, 1996, Pages 317-324

  Moulton, P J ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Cytokines; Inflammation; Joint diseases

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE CHEMOTACTIC FACTOR; NITRIC OXIDE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BONE DESTRUCTION; CARTILAGE DEGENERATION; DISEASE COURSE; HELPER CELL; HUMAN; INFLAMMATION; NEUTROPHIL; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ARTHRITIS; CYTOKINES; HUMANS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REACTIVE OXYGEN SPECIES;

EID: 0030459187     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Lotz M, Blanco FJ, Vonkempis J, Dudler J, Maier R, Villiger PM, Geng Y. Cytokine regulation of chondrocyte functions. J Rheumatol 1995; 22:104-8.
2. Wilson AG, di Giovine FS, Duff GW. Genetics of tumour necrosis factor-α in autoimmune, infectious and neoplastic diseases. J Inflamm 1995; 45:1-12.
3. Thomson AW, ed. The Cytokine Handbook, 2nd edn. London: Academic Press, 1994.
4. Callard RE, Gearing AJH. The Cytokine Facts Book. London: Academic Press, 1994.
5. Pillinger MH, Abramson SB. The neutrophil in rheumatoid arthritis. Rheum Dis Clin N Am 1995; 21:691-714.
6. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor α in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989; 75:306-10.
7. Hachicha M, Rathanaswami P, Schall TJ, McColl SR. Production of monocyte chemotactic protein-1 in human type B synoviocytes. Arthritis Rheum 1993; 36:26-34.
8. Villiger PM, Terkeltaub R, Lotz M. Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. J Clin Invest 1992; 90:488-96.
9. Akahoshi T, Endo H, Kondo H, Kashiwazaki S, Kasahara T, Mukaida N, Harada A, Matsushima K. Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide and interleukin-1. Lymphokine Cytokine Res 1994; 13:113-16.
10. Verburgh CA, Hart MHL, Aarden LA, Swaak AJG. Interleukin-8 (IL-8) in synovial fluid of rheumatoid and non-rheumatoid joint effusions. Clin Rheumatol 1993; 12:494-9.
11. Bertazzolo N, Punzi L, Stefani MP, Cesaro G, Pianon M, Finco B, Todesco S. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 1994; 41:90-2.
12. Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, Matsushima K, Stengaardpedersen K. Localization of interleukin-8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol 1994; 23:2-7.
13. Recklies AD, Golds EE. Induction of synthesis and release of interleukin-8 from human articular chondrocytes and cartilage explants. Arthritis Rheum 1992; 35:1510-19.
14. Beaulieu AD, MeColl SR. Differential expression of 2 major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 1994; 37:855-9.
15. Sato M, Miyazaki T, Nagaya T, Murata Y, Ida N, Maeda K, Seo H. Antioxidants inhibit tumor necrosis factor-α-mediated stimulation of interleukin-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J Rheumatol 1996; 23:432-8.
16. Wozniak A, Betts WH, Murphy GA, Rokicinski M. Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 1993; 79:608-15.
17. McInnes IB, Almughales J, Field M, Leung BP, Huang FP, Dixon R, Sturrock RD, Wilkinson PC, Liew FY. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Mature Med 1996; 2:175-82.
18. Wilkinson PC, Liew FY. Chemoattraction of human blood T-lymphocytes by interleukin-15. J Exp Med 1995; 181:1255-9.
19. Matsumoto T, Iwasaki K. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52:876-80.
20. Steiner G, Studnickabenke A, Witzmann G, Hofler E, Smolen J. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995; 22:406-12.
21. Carotti M, Salaffi F, Ferraccioli GF, Binci MC, Sartini A, Cervini C. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients - correlations with disease activity. Rheumatol Int 1994; 14:47-52.
22. Alsalameh S, Firestein GS, Oez S, Kurrle R, Kalden JR, Burmester GR. Regulation of granulocyte macrophage colony stimulating factor production by human articular chondrocytes. Induction by both tumour necrosis factor-α and interleukin-1, downregulation by transforming growth factor β and upregulation by fibroblast growth factor. J Rheumatol 1994; 21:993-1002.
23. Campbell IK, Ianches G, Hamilton JA. Production of macrophage colony stimulating factor (M-CSF) by human articular cartilage and chondrocytes - modulation by interleukin-1 and tumour necrosis factor-α. Biochim Biophys Acta 1993; 1182:57-63.
24. Campbell IK, Novak L, Cebon J, Layton JE, Hamilton JA. Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-2. J Immunol 1991; 147:1238-46.
25. Campbell IK, Waring P, Novak U, Hamilton JA. Production of leukaemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor-α. Arthritis Rheum 1993; 36:790-4.
26. Hamilton JA, Waring PM, Filonzi EL. Induction of leukemia inhibitory factor in human synovial fibroblasts by IL-1 and tumor necrosis factor-α. J Immunol 1993; 150:1496-502.
27. Germann T, Szeliga J, Hess H, Storkel S, Podlaski FJ, Gately MK, Schmitt E, Rude E. Administration of interleukin-12 in combination with type-II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci USA 1995; 92:4823-7.
28. Hess H, Gately MK, Rude E, Schmitt E, Szeliga J, Germann T. High doses of interleukin-12 inhibit the development of joint disease in DHA/1 mice immunized with type-II collagen in complete Freunds adjuvant. Eur J Immunol 1946; 26: 187-91.
29. Jones BM. Effect of 12 neutralizing anti cytokinc antibodies on in vitro activation of B cells - interleukin-12 is required by B1a but not B2 cells. Scand J Immunol 1996; 43:64-72.
30. Benton HP, Tyler JA. Inhibition of proteoglycan synthesis by imerleukin-1. Biochem Biophys Res Commun 1988; 154:421-8.
31. Arner EC, Pratta MA. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum 1989; 32:288-97.
32. Clay K, Seed MP, Clements-Jewery S. Studies on interleukin-1β induced glycosaminoglycan release from rat femoral head cartilage in vitro. J Pharm Pharmacol 1989; 41:503-4.
33. Arner EC, Tortorella MD. Signal transduction through chrondocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin-1. Arthritis Rheum 1995; 9:1304-14.
34. Chubinskaya S, Huch K, Mikecz K, Csszabo G, Hasty KA, Kuettner KE, Cole AA. Chondrocyte matrix metalloproteinase-8 - up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab Invest 1996; 74:232-40.
35. Lotz M, Rosen F, McCabe G, Quach J, Blanco F, Dudler J, Solan J, Goding J, Seegmiller JE, Terkeltaub R. Interleukin-1β suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci USA 1995; 92:10364-8.
36. Malfait AM, Verbruggen G, Veys EM, Lambert J, Deridder L, Cornelissen M. Comparative and combined effects of interleukin-6, interleukin-1β and tumour necrosis factor-α on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol 1994; 21: 314-20.
37. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, Arbiser JL, Apperley JF. Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994; 94:2307-16.
38. Goldring MB, Fukuo K, Birkhead JR, Dudek E, Sandell LJ. Transcriptional suppression by interleukin-1 and interferon-γ of type II collagen gene expression in human chondrocytes. J Cell Biochem 1994; 54:85-99.
39. Bathon JM, Hwang JJ, Shin LH, Precht PA, Towns MC, Horton WE. Type-VI collagen-specific messenger RNA is expressed constitutively by cultured human synovial fibroblasts and is suppressed by interleukin-1. Arthritis Rheum 1994; 37:1350-6.
40. Vandeloo FAJ, Joosten LAB, Vanlent PLEM, Arntz OJ, Vandenberg WB. Role of interleukin-1, tumor necrosis factor-α and interleukin-6 in cartilage proteoglycan metabolism and destruction-effect of in-situ blocking in murine antigen-induced and zymosan-induced arthritis. Arthritis Rheum 1995; 38:164-72.
41. Olney RC, Wilson DM, Mohtai M, Fielder PJ, Smith RL. Interleukin-1 and tumor necrosis factor-α increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol 1995; 146:279-86.
42. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986; 319:516-18.
43. Dayer J-M, Beutler H, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162:2163-8.
44. Verbruggen G, Malfait A-M, Veys EM, Gyselbrecht L, Lambert J, Almqvist KF. Influence of interferon-γ on isolated chondrocytes from human articular cartilage. Dose dependent inhibition of cell proliferation and proteoglycan synthesis. J Rheumatol 1993; 20:1020-6.
45. Geiger T, Arnold J, Rordorf C, Henn R, Vosbeck K. Interferon-γ overcomes the gluticocorticoid-mediated and the interleukin-4-mediated inhibition of interleukin-1β synthesis in human monocytes. Lymphokine Cytokine Res 1993; 12:271-8.
46. Deleuran B, Iversen L, Deleuran M, Yssel H, Kragballe K, Stengaardpedersen K, Thestruppedersen K. Interleukin-13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC - a comparison between IL-4 and IL-13. Cytokine 1995; 7:319-24.
47. Sugita T, Furukawa O, Ueno M, Murakami T, Takata I, Tosa T. Enhanced expression of interleukin-6 in rat and murine arthritis models. Int J Immunopharmacol 1993; 15:469-76.
48. Pelletier JP, McCollum R, Cloutier JM, Martelpelletier J. Synthesis of metalloproteases and interleukin-6 (IL-6) in human osteoarthritic synovial membrane is an IL-1-mediated process. J Rheumatol 1995; 22:109-14.
49. Vanleeuwen MA, Westra J, Limburg PC, Vanriel PLCM, Vanrijswijk MH. Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid. Ann Rheum Dis 1995; 54:33-8.
50. Arnalich F, Demiguel E, Perezayala C, Martinez M, Vazquez JJ, Gijonbanos J, Hernanz A. Neuropeptides and interleukin-6 in human joint inflammation - relationship between intraarticular substance-P and interleukin-6 concentrations. Neurosci Lett 1994; 170:251-4.
51. Shingu M, Miyauchi S, Nagai Y, Yasutake C, Horie K. The role of IL-4 and IL-6 in Il-1-dependent cartilage matrix degradation. Br J Rheumatol 1995; 34:101-6.
52. Mihara M, Moriya Y, Kishimoto T, Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 1995; 34:321-5.
53. Kotake S, Sato K, Kim KJ, Takahashi N, Udagawa N, Nakamura I, Yamaguchi A, Kishimoto T, Suda T, Kashiwazaki S. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 1996; 11:88-95.
54. Sacerdote P, Carrabba M, Galante A, Pisati R, Manfredi B, Panerai AE. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal antiinflammatory drugs indomethacin, diclofenac and naproxen. Inflamm Res 1995; 44:486-90.
55. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 1993; 268:21527-32.
56. Vanroon JAG, Vanroy JLAM, Duits A, Lafeber FPJG, Bijlsma JW. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial 1-helper 1 activation is inhibited by interleukin-4. Am Rheum Dis 1995; 54:836-40.
57. Miossec P, Chomarat P, Dechanet J, Moreau J-F, Roux J-P, Delmas P, Banchereau J. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of hone resorption in rheumatoid arthritis. Arthritis Rheum 1994; 37:1715-22.
58. Chomarat P, Banchereau J, Miossec P. Differential effects of interleukins-10 and -4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis. Arthritis Rheum 1995; 38:1046-54.
59. Deleuran B, Iversen L, Kristensen M, Field M, Kragballe K, Thestruppedersen K, Stengaardpedersen K. Interleukin-8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: In vivo antiinflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein. Br J Rheumatol 1994; 33:520-5.
60. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 1995; 84: 536-42.
61. Taylor DJ. Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumor necrosis factor receptor and inhibits TNF-α-S effect on rheumatoid synovial fibroblasts. Rheumatol Int 1994; 14:21-5.
62. Katz Y, Stav D, Barr J, Passwell JH. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumor necrosis factor (TNF)-stimulated fibroblasts. Clin Exp Immunol 1995; 101:150-6.
63. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995; 95:2868-76.
64. Lapadula G, Iannone F, Dell'Accio F, Covelli M, Pipitone V. Interleukin-10 in rheumatoid arthritis. Clin Exp Rheumatol 1995; 13:629-32.
65. Sugiyama E, Kuroda A, Taki H, Ikemoto M, Hoto T, Yamashita N, Maruyama M, Kobayashi M. Interleukin-10 cooperates with interleukin-4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells. J Rheumatol 1995; 22:2020-6.
66. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. Induction of cyclooxygenase by interleukin-1 - comparative study between human synovial cells and chondrocytes. J Rheumatol 1994; 21:462-6.
67. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, Hla T. Cyclooxygenase-1 and cyclooxygenase-2 expression in rheumatoid synovial tissues - effects of interleukin-1β, phorbol ester and corticosteroids. J Clin Invest 1994; 93:1095-101.
68. Hulkower KI, Wertheimer SJ, Levin W, Coffey JW, Anderson CM, Chen T, Dewitt DL, Growl RM, Hope WC, Morgan DW. Interleukin-1β induces cytosolic phospholipase A(2) and prostaglandin-H synthase in rheumatoid synovial fibroblasts - evidence for their roles in the production of prostaglandin E(2). Arthritis Rheum 1994; 37:653-61.
69. Dibattista JA, Martelpelletier J, Morin N, Jolicoeur FC, Pelletier JP. Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E(2) - mediation by protein kinase A and role of interleukin-1. Mol Cell Endocrinol 1994; 103:139-48.
70. Angel J, Berenbaum F, Ledenmat C, Nevalainen T, Masliah J, Fournier C. Interleukin-1-induced prostaglandin E(2) biosynthesis in human synovial cells involves the activation of cytosolic phospholipase A(2) and cyclooxygenase-2. Eur J Biochem 1994; 226:125-31.
71. Roshak A, Mochan E, Marshall LA. Suppression of human synovial fibroblast 85KDa phospholipase A(2) by antisense reduces interleukin-1β induced prostaglandin E(2). J Rheumatol 1996; 23:420-7.
72. Hoffman BR, Kandel RA, Cruz TF. Effect of phorbol ester on the inhibition of proteoglycan synthesis by interleukin-1 and antiinflammatory drugs. J Rheumatol 1993; 20: 1741-6.
73. Vincenti MP, Coon CI, White LA, Barchowski A, Brinckerhoff CE. Src-related tyrosine kinases regulate transcriptional activation of the interstitial collagenase gene, MMP-1, in interleukin-1-stimulated synovial fibroblasts. Arthritis Rheum 1996; 39: 574-82.
74. Kehrer JP. Free-radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23:21-48.
75. Fairburn K, Stevens CR, Winyard PG, Kus M, Ward RJ, Cunningham J, Zaidi M, Blake DR. Oxidative stress and its control - a pathogenic role in inflammatory joint disease. Biochem Soc Trans 1993; 21:372-5.
76. Davies KJA. Oxidative stress - the paradox of aerobic life. Biochem Soc Symp 1995; 61:1-31.
77. Henrotin Y, Debydupont G, Deby C, Debruyn M, Lamy M, Franchimont P. Production of active oxygen species by isolated human chondrocytes. Br J Rheumatol 1993; 32:562-7.
78. Tiku ML, Liesch JB, Robertson FM. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 1990; 145:690-6.
79. Hiran T, Moulton P, Hancock JT. Superoxide production in articular chondrocytes by a phagocyte-like NADPH oxidase. Eur J Clin Invest 1995; 25(S2):A26.
80. Dewar CL, Harth M. Superoxide production from cytokine-treated adherent rheumatoid neutrophils. Clin Invest Med 1994; 17:52-60.
81. Eggleton P, Wang L, Penhallow J, Crawford N, Brown KA. Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54:916-23.
82. Meier B, Radeke HH, Selle S, Younes M, Sies H, Resch K, Habermehl GG. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem J 1989; 263:539-45.
83. Moulton PJ, Hiran T, Hancock JT. Superoxide production in an immortalized human chondrocyte cell line by a phagocyte-like NADPH oxidase. Eur J Clin Invest 1996; 26(S1):A33.
84. Lo YYC, Cruz TF. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 1995; 270:11727-30.
85. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NFκβ in human synovial cells in response to tumor necrosis factor-α. Arthritis Rheum 1996; 39:197-203.
86. Shingu M, Isayama T, Yasutake C, Naono T, Nobunaga M, Tomari K, Horie K, Goto Y. Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation. Inflammation 1994; 18:613-23.
87. Panasyuk A, Frati E, Ribault D, Mitrovic D. Effect of reactive oxygen species on the biosynthesis and structure of newly synthesized proteoglycans. Free Radicals Biol Med 1994; 16: 157-67.
88. Shingu M, Takahashi S, Ito M, Hamamatu N, Suenaga Y, Ichibangase Y, Nobunaga M. Antiinflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats. Rheumatol Int 1994; 14:77-81.
89. Fukuda K, Dan H, Saitoh M, Takayama M, Tanaka S. Superoxide dismutase inhibits interleukin-1 induced degradation of human cartilage. Agents Actions 1994; 42:71-3.
90. Miesel R, Sanocka D, Kurpisz M, Kroger H. Antiinflammatory effects of NADPH oxidase inhibitors. Inflammation 1995; 19: 347-62.
91. Melli M, Yazici H, Ucar A, Turker RK. Inhibitory effect of allopurinol on adjuvant arthritis in rats. Agents Actions 1994; 42:56-9.
92. Zhou Y, Lin G, Murtaugh MP. Interleukin-4 suppresses the expression of macrophage NADPH oxidase heavy chain subunit (gp91-phox). Biochim Biophys Acta 1995; 1265:40-8.
93. Sozzani P, Cambon C, Vita N, Seguelas M-H, Caput D, Ferrara P, Pipy B. Interleukin-13 inhibits protein kinase C-triggered respiratory burst in human monocytes. J Biol Chem 1995; 270:5084-8.
94. Tithof PK, Schiamberg E, Petersgolden M, Ganey PE. Phospholipase A(2) is involved in the mechanism of activation of neutrophils by poly-chlorinated biphenyls. Environ Health Perspectives 1996; 104:52-8.
95. Miles AM, Bohle DS, Glassbrenner PA, Hansen B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271:40-7.
96. Tsuji M, Funahashi S, Takigawa M, Seiki M, Fujii K, Yoshida T. Expression of c-fos gene inhibits proteoglycan synthesis in transfected chondrocyte. FEBS Lett 1996; 381:222-6.
97. Kuroki Y, Shiozawa S, Sugimoto T, Kanatani M, Kaji H, Miyauchi A, Chihara K. Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption. Clin Exp Immunol 1994; 95:536-9.
98. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995; 57:737-69.
99. Griffith OW, Stuehr DJ. Nitric oxide synthases: properties and catalytic mechanism. Annu Rev Physiol 1995; 57:707-36.
100. Murrell GAC, Dolan MM, Jang D, Szabo C, Warren RF, Hannafin JA. Nitric oxide - an important articular free-radical. J Bone Joint Surg - Am Vol 1996; 78A:265-74.
101. Evans DM, Ralston SH. Nitric oxide and bone. J Bone Min Res 1996; 11:300-5.
102. Moilanen E, Vapaatalo H. Nitric oxide in inflammation and immune response. Ann Med 1995; 27:359-67.
103. Hall TJ, Gasser J, Feige U, Ferrini PG. Effects of the cytokine synthesis inhibitor CGP 47969A on nitric oxide production by lipopolysaccharide-stimulated J774A.1 macrophages. Agents Actions 1994; 43:60-3.
104. Stefanovicracic M, Morales TI, Taskiran D, McIntyre LA, Evans CH. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Immunol 1996; 156:1213-20.
105. Frears ER, Zhang Z, Blake DR, O'Connell JP, Winyard PG. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 1996; 381:21-4.
106. Miesel R, Ehrlich W, Wohlert H, Kurpisz M, Kroger H. The effects of interleukin-1 receptor antagonist on oxidant-induced arthritis in mice. Clin Exp Rheumatol 1995; 13:595-601.
107. Murrell GAC, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995; 206:15-21.
108. Fukuda K, Kumano F, Takayama M, Saito M, Otani K, Tanaka S. Zonal differences in nitric oxide synthesis by bovine chondrocytes exposed to interleukin-1. Inflamm Res 1995; 44: 434-7.
109. Jarvinen TAH, Moilanen T, Jarvinen TLN, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediat Inflamm 1995; 4:107-11.
110. Hauselmann HJ, Oppliger L, Michel BA, Stefanovicracic M, Evans CH. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994; 352:361-4.
111. Blanco FJ, Lotz M. IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 1995; 218:319-25.
112. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 1996; 23:230-6.
113. McCartney Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, Wahl SM. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178:749-54.
114. Oyanagui Y. Nitric oxide and superoxide radical are involved in both initiation and development of adjuvant arthritis in rats. Life Sci 1994; 54:PL285-9.
115. Miesel R, Kurpisz M, Kroger H. Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase. Free Radical Biol Med 1996; 20:75-81.
116. Aeberhard EE, Henderson SA, Arabolos NS, Griscavage JM, Castro FE, Barrett CT, Ignarro LJ. Nonsteroidal antiinflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochem Biophys Res Commun 1995; 208:1053-9.
117. Maier R, Bilbe G, Rediske J, Lotz M. Inducible nitric oxide synthase from human articular chondrocytes-cDNA cloning and analysis of messenger RNA expression. Biochim Biophys Acta - Prot Struc Mol Enzymol 1994; 1208:145-50.
118. Stefanovicracic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 1994; 21:1892-8.
119. Sakuri H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96:2357-63.
120. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994; 135: 330-6.
121. Yaqoob P, Calder P. Effects of dietary-lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 1995; 163:120-8.
122. Pelletier JP, Mineau F, Ranger P, Tardif G, Martelpelletier J. The increased synthesis of inducible nitric oxide inhibits IL-1Ra synthesis by human articular chondrocytes possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 1996; 4:77-84.
123. Grabowski PS, MacPherson H, Ralston SH. Nitric oxide production in cells derived from the human joint. Br J Rheumatol 1996; 35:207-12.
124. Liew FY. Nitric oxide in infectious and autoimmune diseases. CIBA Foundation Symp 1995; 195:234-9.
125. Miller L, Alley EW, Murphy WJ, Russell SW, Hunt JS. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J Leukocyte Biol 1996; 59:442-50.
126. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol 1995; 15:77-105.
127. Ehrlich W, Huser H, Kroger H. Inhibition of the induction of collagenase by interleukin-1β in cultured rabbit synovial fibroblasts after treatment with the poly(ADP-ribose) polymerase inhibitor 3-aminobenzamide. Rheumatol Int 1995; 146:171-2.
128. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146:75-85.
129. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Johnston PW, Benjamin N. Nitric oxide - a cytokine-induced regulator of bone resorption. J Bone Min Res 1995; 10:1040-9.
130. Hukkanen M, Hughes FJ, Buttery LDK, Gross SS, Evans TJ, Seddon S, Riverosmoreno V, MacIntyre I, Polak JM. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 1995; 136: 5445-53.
131. Maini RN. A perspective on anti-cytokine and anti-T cell-directed therapies in rheumatoid arthritis. Clin Exp Rheumatol 1995; 13:S35-40.
132. Vandeputte LBA, Vanriel PLCM. Rheumatoid arthritis - new trends in therapy. Clin Exp Rheumatol 1995; 13:827-30.
133. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14:397-440.